Rigel Pharmaceuticals | RIGL - Stock


Rigel Pharmaceuticals reported $13.3M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Amgen USD 6.22B 34M Jun/2026
Anika Therapeutics USD 28.56M 5.73M Jun/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
AstraZeneca USD 6.93B 362M Jun/2026
BioMarin Pharmaceutical USD 1.78B 509.3M Jun/2026
Bristol-Myers Squibb USD 2.74B 19M Jun/2026
Daiichi Sankyo JPY 692.38B 83.83B Mar/2026
Eli Lilly USD 16.79B 2.26B Jun/2026
Halozyme Therapeutics USD 137.14M 18.33M Jun/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Intrexon USD 287K 68K Dec/2022
Ionis Pharmaceuticals USD 50.83M 45.28M Jun/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Ligand Pharmaceuticals USD 10.26M 3M Jun/2026
MacroGenics USD 9.5M 1.59M Mar/2026
Neurocrine Biosciences USD 104.2M 39.7M Jun/2026
Pfizer USD 9.94B 722M Jun/2026
Regeneron Pharmaceuticals USD 3.08B 19.3M Jun/2026
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Ultragenyx Pharmaceutical USD 59M 4M Jun/2026
Veracyte USD 22.66M 1.24M Jun/2026